These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 9554264)

  • 1. Systemic immunization with conserved pilus-associated adhesins protects against mucosal infections.
    Palaszynski S; Pinkner J; Leath S; Barren P; Auguste CG; Burlein J; Hultgren S; Langermann S
    Dev Biol Stand; 1998; 92():117-22. PubMed ID: 9554264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli.
    Langermann S; Möllby R; Burlein JE; Palaszynski SR; Auguste CG; DeFusco A; Strouse R; Schenerman MA; Hultgren SJ; Pinkner JS; Winberg J; Guldevall L; Söderhäll M; Ishikawa K; Normark S; Koenig S
    J Infect Dis; 2000 Feb; 181(2):774-8. PubMed ID: 10669375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination.
    Langermann S; Palaszynski S; Barnhart M; Auguste G; Pinkner JS; Burlein J; Barren P; Koenig S; Leath S; Jones CH; Hultgren SJ
    Science; 1997 Apr; 276(5312):607-11. PubMed ID: 9110982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection.
    Thankavel K; Madison B; Ikeda T; Malaviya R; Shah AH; Arumugam PM; Abraham SN
    J Clin Invest; 1997 Sep; 100(5):1123-36. PubMed ID: 9276729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal immunization with fusion protein MrpH·FimH and MPL adjuvant confers protection against urinary tract infections caused by uropathogenic Escherichia coli and Proteus mirabilis.
    Habibi M; Asadi Karam MR; Shokrgozar MA; Oloomi M; Jafari A; Bouzari S
    Mol Immunol; 2015 Apr; 64(2):285-94. PubMed ID: 25562574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal immunization with a recombinant truncated FimH adhesin adjuvanted with CpG oligodeoxynucleotides protects mice against uropathogenic Escherichia coli challenge.
    Poggio TV; La Torre JL; Scodeller EA
    Can J Microbiol; 2006 Nov; 52(11):1093-102. PubMed ID: 17215901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an anti-adhesive vaccine for Pseudomonas aeruginosa targeting the C-terminal region of the pilin structural protein.
    Sheth HB; Glasier LM; Ellert NW; Cachia P; Kohn W; Lee KK; Paranchych W; Hodges RS; Irvin RT
    Biomed Pept Proteins Nucleic Acids; 1995; 1(3):141-8. PubMed ID: 9346845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of protective immunity after escherichia coli bladder infection in primates. Dependence of the globoside-specific P-fimbrial tip adhesin and its cognate receptor.
    Söderhäll M; Normark S; Ishikawa K; Karlsson K; Teneberg S; Winberg J; Möllby R
    J Clin Invest; 1997 Jul; 100(2):364-72. PubMed ID: 9218513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the effect of MPL and delivery route on immunogenicity and protectivity of different formulations of FimH and MrpH from uropathogenic Escherichia coli and Proteus mirabilis in a UTI mouse model.
    Habibi M; Asadi Karam MR; Bouzari S
    Int Immunopharmacol; 2015 Sep; 28(1):70-8. PubMed ID: 26033493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fimch antiserum inhibits the adherence of Escherichia coli to cells collected by voided urine specimens of diabetic women.
    Meiland R; Geerlings SE; Langermann S; Brouwer EC; Coenjaerts FE; Hoepelman AI
    J Urol; 2004 Apr; 171(4):1589-93. PubMed ID: 15017227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of immune responses of the flagellin (FliC) fused to FimH adhesin of Uropathogenic Escherichia coli.
    Karam MR; Oloomi M; Mahdavi M; Habibi M; Bouzari S
    Mol Immunol; 2013 May; 54(1):32-9. PubMed ID: 23220068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral immunization of mice with plant-derived fimbrial adhesin FaeG induces systemic and mucosal K88ad enterotoxigenic Escherichia coli-specific immune responses.
    Liang W; Huang Y; Yang X; Zhou Z; Pan A; Qian B; Huang C; Chen J; Zhang D
    FEMS Immunol Med Microbiol; 2006 Apr; 46(3):393-9. PubMed ID: 16553813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection.
    Hung CS; Bouckaert J; Hung D; Pinkner J; Widberg C; DeFusco A; Auguste CG; Strouse R; Langermann S; Waksman G; Hultgren SJ
    Mol Microbiol; 2002 May; 44(4):903-15. PubMed ID: 12010488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral immunization of piglets with recombinant F4 fimbrial adhesin FaeG monomers induces a mucosal and systemic F4-specific immune response.
    Verdonck F; Cox E; Van der Stede Y; Goddeeris BM
    Vaccine; 2004 Oct; 22(31-32):4291-9. PubMed ID: 15474721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of broiler chickens to Escherichia coli respiratory tract infection induced by passively transferred egg-yolk antibodies.
    Kariyawasam S; Wilkie BN; Gyles CL
    Vet Microbiol; 2004 Mar; 98(3-4):273-84. PubMed ID: 15036536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptors for Escherichia coli adhesins in the genitourinary tract in a non-human primate.
    Ishikawa K; Sundelin B; Möllby R; Normark S; Winberg J
    Scand J Urol Nephrol; 2004; 38(1):3-14. PubMed ID: 15204420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli.
    Billips BK; Yaggie RE; Cashy JP; Schaeffer AJ; Klumpp DJ
    J Infect Dis; 2009 Jul; 200(2):263-72. PubMed ID: 19522648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin.
    Bouckaert J; Berglund J; Schembri M; De Genst E; Cools L; Wuhrer M; Hung CS; Pinkner J; Slättegård R; Zavialov A; Choudhury D; Langermann S; Hultgren SJ; Wyns L; Klemm P; Oscarson S; Knight SD; De Greve H
    Mol Microbiol; 2005 Jan; 55(2):441-55. PubMed ID: 15659162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased tracheal colonization in chickens without impairing pathogenic properties of avian pathogenic Escherichia coli MT78 with a fimH deletion.
    Arné P; Marc D; Brée A; Schouler C; Dho-Moulin M
    Avian Dis; 2000; 44(2):343-55. PubMed ID: 10879915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biofilm formation in a hydrodynamic environment by novel fimh variants and ramifications for virulence.
    Schembri MA; Klemm P
    Infect Immun; 2001 Mar; 69(3):1322-8. PubMed ID: 11179294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.